Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients
Clinical trial NCT05065801 · RECRUITING
Trial details
- NCT number
- NCT05065801
- Sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-11
- Primary completion
- 2026-12-30
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.